NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: Neuren completes enrolment in INTREPID clinical trial, page-8

  1. 2,647 Posts.
    lightbulb Created with Sketch. 432
    Just a brief note to point out that the clinicaltrials site has been updated (28 Oct) to reflect the situation as set out in recent anns.

    The FXS trial declared finished in October. The TBI trial declared as finished recruiting but ongoing, due to finish Jan 2016.

    No surprises there.

    The only thing I'm drawing from this is that, given they were updating the information, the concussion trial is still as it was updated on 8 Oct, with a completion date listed for June 2016.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.